4.2 Article

Associations between Patterns of EEG Abnormalities and Diagnosis in a Large Memory Clinic Cohort

Journal

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Volume 27, Issue 1, Pages 18-23

Publisher

KARGER
DOI: 10.1159/000182422

Keywords

EEG abnormalities; Dementia; Visual analysis, diagnosis

Ask authors/readers for more resources

Aim: To describe associations of abnormalities in the electroencephalogram (EEG) with the most prevalent diagnoses in a memory clinic cohort. Methods: Associations between visual EEG findings and diagnoses in 1,116 consecutive patients [382 Alzheimer's disease (AD), 274 subjective complaints, 190 mild cognitive impairment (MCI), 118 psychiatric disorder, 61 frontotemporal lobar degeneration, 53 vascular dementia (VaD), 38 dementia with Lewy bodies (DLB)] were determined by prevalence ratio (PR). Results: Diagnoses of subjective complaints [PR = 1.6; 95% confidence interval (CI) = 1.4-1.9] and psychiatric disorder (1.4; 95% CI = 1.1-1.9) were associated with a normal EEG, while subjects with both focal and diffuse EEG disturbances were more likely to have DLB (3.5; 95% CI = 2.1-5.6), VaD (2.3; 95% CI = 1.4-3.6) or AD (1.5; 95% CI = 1.3-1.8). Subjects with only diffuse EEG abnormalities were more likely to have AD ( PR = 1.5; 95% CI = 1.3-1.9). The prevalence of MCI was higher among those with only focal EEG abnormalities ( PR = 1.3; 95% CI = 1.0-1.7). Conclusions: A normal EEG argues for subjective complaints or psychiatric diagnosis. An EEG with only focal abnormalities supports MCI. An EEG with only diffuse abnormalities argues for AD. An EEG with both focal and diffuse abnormalities argues for DLB, VaD or AD. Copyright (c) 2008 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Combining advanced MRI and EEG techniques better explains long-term motor outcome after very preterm birth

Charlotte van't Westende, Sylke J. Steggerda, Lisette Jansen, Annette A. van den Berg-huysmans, Laura A. van de Pol, Francisca T. Wiggers-de Bruine, Cornelis J. Stam, Cacha M. P. C. D. Peeters-Scholte

Summary: This study investigates the relationship between motor outcome and advanced MRI and EEG measures in preterm born children at school age. The results show that ventricular volume and relative upper alpha power on EEG are independently associated with motor outcome, indicating a lasting interplay between brain structure and function underlying adverse motor outcome.

PEDIATRIC RESEARCH (2022)

Article Geriatrics & Gerontology

Neuropsychiatric Symptoms as Predictor of Poor Clinical Outcome in Patients With Vascular Cognitive Impairment

Yoni C. P. Sep, Anna E. Leeuwis, Lieza G. Exalto, Jooske M. Boomsma, Niels D. Prins, Jurre H. Verwer, Philip Scheltens, Wiesje M. van der Flier, Geert Jan Biessels, TRACE-VCI study group Behalf TRACE VCI Study Grp

Summary: This study examines the association between neuropsychiatric symptoms (NPS) and clinical outcomes in memory clinic patients with possible Vascular Cognitive Impairment (VCI). The findings reveal that NPS are common in this patient group and are associated with institutionalization, mortality, and cognitive deterioration. The association between NPS and clinical outcomes varies depending on the severity of cognitive impairment.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2022)

Article Pharmacology & Pharmacy

Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease

Anne Catrien Baakman, Carmen Gavan, Lotte van Doeselaar, Marieke de Kam, Karen Broekhuizen, Ovidiu Bajenaru, Laura Camps, Eleonora L. Swart, Kees Kalisvaart, Niki Schoonenboom, Evelien Lemstra, Philip Scheltens, Adam Cohen, Joop van Gerven, Geert Jan Groeneveld

Summary: This study investigates the acute pharmacodynamic effects of galantamine in AD patients and finds that the acute changes in CNS functioning after a single dose of galantamine can predict long-term treatment response.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Neurosciences

Cellular Substrates of Functional Network Integration and Memory in Temporal Lobe Epilepsy

Linda Douw, Ida A. Nissen, Sophie M. D. D. Fitzsimmons, Fernando A. N. Santos, Arjan Hillebrand, Elisabeth C. W. van Straaten, Cornelis J. Stam, Philip C. De Witt Hamer, Johannes C. Baayen, Martin Klein, Jaap C. Reijneveld, Djai B. Heyer, Matthijs B. Verhoog, Rene Wilbers, Sarah Hunt, Huibert D. Mansvelder, Jeroen J. G. Geurts, Christiaan P. J. de Kock, Natalia A. Goriounova

Summary: This study investigates the cellular substrates of functional network integration in patients with temporal lobe epilepsy (TLE). The findings show that functional network centrality is related to memory performance and cellular integrative properties. These findings provide insights into the focal pathology and network disturbances in TLE.

CEREBRAL CORTEX (2022)

Article Clinical Neurology

Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial

Agnetha D. Fruijtier, Jetske van der Schaar, Ingrid S. van Maurik, Marissa D. Zwan, Philip Scheltens, Femke Bouwman, Yolande A. L. Pijnenburg, Bart N. M. van Berckel, Jarith Ebenau, Wiesje M. van der Flier, Ellen M. A. Smets, Leonie N. C. Visser

Summary: This study investigated the impact of six communication strategies on amyloid disclosure in mild cognitive impairment (MCI) patients. It found that risk communication best practices resulted in the highest information recall, while recall in emotional support was better than the basic and elaborate information strategies. Risk communication best practices also led to the highest uncertainty, while teach-back and emotional support contributed to the highest evaluations of the physician and information. Overall, risk communication best practices, attending to emotions, and teach-back techniques enhance information recall and contribute to positive care evaluations for amyloid-PET results.

ALZHEIMERS & DEMENTIA (2023)

Article Health Care Sciences & Services

Giving meaning to the scores of the Amsterdam instrumental activities of daily living questionnaire: a qualitative study

Mark A. Dubbelman, Caroline B. Terwee, Merike Verrijp, Leonie N. C. Visser, Philip Scheltens, Sietske A. M. Sikkes

Summary: The study established clinically meaningful scoring categories for the Amsterdam IADL questionnaire, providing guidance for clinicians to interpret scores and communicate with patients and caregivers effectively.

HEALTH AND QUALITY OF LIFE OUTCOMES (2022)

Article Neurosciences

Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study

Janne J. Luppi, Deborah N. Schoonhoven, Anne M. van Nifterick, Alida A. Gouw, Arjan Hillebrand, Philip Scheltens, Cornelis J. Stam, Willem de Haan

Summary: This study detected oscillatory abnormalities of the hippocampus in prodromal AD patients using MEG technology. Hippocampus-based classification performed better than cortex-based classification, which may improve early detection of AD-related neuronal dysfunction.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Correction Clinical Neurology

Structural and functional correlates of deep brain stimulation-induced apathy in Parkinson's disease (vol 14, pg 192, 2021)

Lennard I. iii Boon, Wouter V. Potters, Thomas J. C. Zoon, Odile A. van den Heuvel, Naomi Prent, Rob M. A. de Bie, Maarten Bot, P. Richard Schuurman, Pepijn Van den Munckhof, Cornelis J. Stam, Arjan Hillebrand, Gert J. Geurtsen, Anne-Fleur van Rootselaar, Henk W. Berendse

BRAIN STIMULATION (2022)

Article Endocrinology & Metabolism

Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals

Fiona Heeman, Denise Visser, Maqsood Yaqub, Sander Verfaillie, Tessa Timmers, Yolande A. L. Pijnenburg, Wiesje M. van der Flier, Bart N. M. van Berckel, Ronald Boellaard, Adriaan A. Lammertsma, Sandeep S. Golla

Summary: Alzheimer's disease is characterized by reduced cerebral blood flow. This study compared the precision of different methods for measuring cerebral blood flow and found that relative blood flow methods had better repeatability than absolute blood flow methods. The high precision of relative blood flow may be due to a compensatory effect of the extraction fraction.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2023)

Article Geriatrics & Gerontology

Determinants of quality of life in family caregivers in MCI: a comparison with mild dementia

Eva Y. L. Tan, Niels Janssen, Ron Handels, Inez H. G. B. Ramakers, Frans R. J. Verhey, Wiesje M. van der Flier, Rene J. F. Melis, Marcel G. M. Olde Rikkert, Jos M. G. A. Schols, Marjolein E. de Vugt

Summary: The objective of this study was to investigate the health-related quality of life (HRQol) of family caregivers of individuals with mild cognitive impairment (MCI), and to explore possible determinants and differences compared to caregivers of individuals with mild dementia. The study found no significant difference in HRQoL between family caregivers of individuals with MCI and mild dementia. However, caregiver characteristics, such as being a spouse and having a lower educational level, were associated with lower HRQoL.

AGING & MENTAL HEALTH (2023)

Article Multidisciplinary Sciences

What does heritability of Alzheimer's disease represent?

Emily Baker, Ganna Leonenko, Karl Michael Schmidt, Matthew Hill, Amanda J. Myers, Maryam Shoai, Itziar de Rojas, Niccolo Tesi, Henne Holstege, Wiesje M. van der Flier, Yolande A. L. Pijnenburg, Agustin Ruiz, John Hardy, Sven van der Lee, Valentina Escott-Price

Summary: Late-onset Alzheimer's disease has a strong genetic component, and the heritability estimates range from 38% to 66%. The APOE region and microglial-related genes play important roles in the genetic architecture of the disease.

PLOS ONE (2023)

Editorial Material Clinical Neurology

Treatments for AD: towards the right target at the right time

Wiesje M. van der Flier, Betty M. Tijms

NATURE REVIEWS NEUROLOGY (2023)

Article Clinical Neurology

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study

Yanaika S. S. Hok-A-Hin, Katharina Bolsewig, Daimy N. N. Ruiters, Alberto Lleo, Daniel Alcolea, Afina W. W. Lemstra, Wiesje M. M. van der Flier, Charlotte E. E. Teunissen, Marta del Campo

Summary: Our study showed that THOP1 can serve as an early specific biomarker for Alzheimer's Disease (AD). We developed THOP1 immunoassays and validated our findings in two independent cohorts.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

Article Cell Biology

Towards a future where Alzheimer's disease pathology is stopped before the onset of dementia

Wiesje M. van der Flier, Marjolein E. de Vugt, Ellen M. A. Smets, Marco Blom, Charlotte E. Teunissen

Summary: Alzheimer's disease is a significant healthcare challenge with no current cure. This perspective proposes a strategy to shift the focus towards the pre-dementia stages and invest in personalized medicine for diagnosis, prediction and prevention. It suggests empowering patients and the public to actively participate in managing their health and disease, and developing improved strategies for early intervention.

NATURE AGING (2023)

Article Clinical Neurology

Development and design of a diagnostic report to support communication in dementia: Co-creation with patients and care partners

Aniek M. M. van Gils, Leonie N. C. Visser, Heleen M. A. Hendriksen, Jean Georges, Wiesje M. M. van der Flier, Hanneke F. M. Rhodius-Meester

Summary: This study aimed to develop a personalized diagnostic report through a mixed-methods approach, involving surveys and focus group discussions with patients and care partners. The majority of participants valued the diagnostic report for summarizing test results in a brief and straightforward manner, including brain imaging and future expectations. Co-creation was identified as highly valuable in meeting the specific needs of end-users during the iterative design process.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2022)

No Data Available